Innate Immunity to Respiratory Infection in Early Life
- PMID: 29184555
- PMCID: PMC5694434
- DOI: 10.3389/fimmu.2017.01570
Innate Immunity to Respiratory Infection in Early Life
Abstract
Early life is a period of particular susceptibility to respiratory infections and symptoms are frequently more severe in infants than in adults. The neonatal immune system is generally held to be deficient in most compartments; responses to innate stimuli are weak, antigen-presenting cells have poor immunostimulatory activity and adaptive lymphocyte responses are limited, leading to poor immune memory and ineffective vaccine responses. For mucosal surfaces such as the lung, which is continuously exposed to airborne antigen and to potential pathogenic invasion, the ability to discriminate between harmless and potentially dangerous antigens is essential, to prevent inflammation that could lead to loss of gaseous exchange and damage to the developing lung tissue. We have only recently begun to define the differences in respiratory immunity in early life and its environmental and developmental influences. The innate immune system may be of relatively greater importance than the adaptive immune system in the neonatal and infant period than later in life, as it does not require specific antigenic experience. A better understanding of what constitutes protective innate immunity in the respiratory tract in this age group and the factors that influence its development should allow us to predict why certain infants are vulnerable to severe respiratory infections, design treatments to accelerate the development of protective immunity, and design age specific adjuvants to better boost immunity to infection in the lung.
Keywords: infection; innate immunity; neonatal; respiratory; respiratory syncytial virus.
Figures

Similar articles
-
Mycobacterium bovis BCG Given at Birth Followed by Inactivated Respiratory Syncytial Virus Vaccine Prevents Vaccine-Enhanced Disease by Promoting Trained Macrophages and Resident Memory T Cells.J Virol. 2023 Mar 30;97(3):e0176422. doi: 10.1128/jvi.01764-22. Epub 2023 Feb 13. J Virol. 2023. PMID: 36779760 Free PMC article.
-
Induction and Subversion of Human Protective Immunity: Contrasting Influenza and Respiratory Syncytial Virus.Front Immunol. 2018 Mar 2;9:323. doi: 10.3389/fimmu.2018.00323. eCollection 2018. Front Immunol. 2018. PMID: 29552008 Free PMC article. Review.
-
Surfactant Protein-A and its immunomodulatory roles in infant respiratory syncytial virus infection: a potential for therapeutic intervention?Am J Physiol Lung Cell Mol Physiol. 2025 Jan 1;328(1):L179-L196. doi: 10.1152/ajplung.00199.2024. Epub 2024 Dec 11. Am J Physiol Lung Cell Mol Physiol. 2025. PMID: 39662519 Review.
-
Severe respiratory syncytial virus disease in preterm infants: a case of innate immaturity.Thorax. 2021 Sep;76(9):942-950. doi: 10.1136/thoraxjnl-2020-216291. Epub 2021 Feb 11. Thorax. 2021. PMID: 33574121 Review.
-
Formulation of the respiratory syncytial virus fusion protein with a polymer-based combination adjuvant promotes transient and local innate immune responses and leads to improved adaptive immunity.Vaccine. 2016 Sep 30;34(42):5114-5124. doi: 10.1016/j.vaccine.2016.08.053. Epub 2016 Aug 31. Vaccine. 2016. PMID: 27591951
Cited by
-
Innate Immune Evasion by Human Respiratory RNA Viruses.J Innate Immun. 2020;12(1):4-20. doi: 10.1159/000503030. Epub 2019 Oct 14. J Innate Immun. 2020. PMID: 31610541 Free PMC article. Review.
-
First Pediatric Case of Coronavirus Disease 2019 in Korea.J Korean Med Sci. 2020 Mar 23;35(11):e124. doi: 10.3346/jkms.2020.35.e124. J Korean Med Sci. 2020. PMID: 32193905 Free PMC article.
-
High burden of viruses and bacterial pathobionts drives heightened nasal innate immunity in children.J Exp Med. 2024 Sep 2;221(9):e20230911. doi: 10.1084/jem.20230911. Epub 2024 Jul 1. J Exp Med. 2024. PMID: 38949638 Free PMC article.
-
Akt Inhibition Promotes Autophagy and Clearance of Group B Streptococcus from the Alveolar Epithelium.Pathogens. 2022 Sep 30;11(10):1134. doi: 10.3390/pathogens11101134. Pathogens. 2022. PMID: 36297190 Free PMC article.
-
A dynamic transmission model for assessing the impact of pneumococcal vaccination in the United States.PLoS One. 2025 Apr 2;20(4):e0305892. doi: 10.1371/journal.pone.0305892. eCollection 2025. PLoS One. 2025. PMID: 40173185 Free PMC article.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources